|
Reactivity/
Applications |
H, R, M/IF WB IHC-p |
|
Size/Price |
50ug/1000 100ug/1800 |
|
Gene_Name/
Protein_Name |
PPIB/Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP) |
|
Human_gene_id/
Human_swiss_prot_no |
5479/P23284 |
|
Mouse_gene_id/
Mouse_swiss_prot_no |
/P24369 |
|
Rat_gene_id/
Rat_swiss_prot_no |
/P24368 |
|
Immunogen |
Synthetic Peptide of Cyclophilin B |
|
Specificity |
Cyclophilin B protein detects endogenous levels of Cyclophilin B |
|
Formulation |
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
|
|
Dilution |
IF: 1:50-200 WB 1:1000-2000 IHC 1:50-300 |
|
Purification |
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. |
|
|
Storage_stability |
-20°C/1 year |
|
Other_name |
PPIB; CYPB; Peptidyl-prolyl cis-trans isomerase B; PPIase B; CYP-S1; Cyclophilin B; Rotamase B; S-cyclophilin; SCYLP |
|
Predicted_band(Da)/
Observed_band(KD) |
/21 |
|
|
| Content |
|
Immunohistochemical analysis of paraffin-embedded Human-uterus tissue. 1,Cyclophilin B Monoclonal Antibody(2B10) was diluted at 1:200(4°C,overnight). 2, Sodium citrate pH 6.0 was used for antibody retrieval(>98°C,20min). 3,Secondary antibody was diluted at 1:200(room tempeRature, 30min). Negative control was used by secondary antibody only. |
|
|
Immunohistochemical analysis of paraffin-embedded Rat-lung tissue. 1,Cyclophilin B Monoclonal Antibody(2B10) was diluted at 1:200(4°C,overnight). 2, Sodium citrate pH 6.0 was used for antibody retrieval(>98°C,20min). 3,Secondary antibody was diluted at 1:200(room tempeRature, 30min). Negative control was used by secondary antibody only. |
|
|
Immunohistochemical analysis of paraffin-embedded Mouse-lung tissue. 1,Cyclophilin B Monoclonal Antibody(2B10) was diluted at 1:200(4°C,overnight). 2, Sodium citrate pH 6.0 was used for antibody retrieval(>98°C,20min). 3,Secondary antibody was diluted at 1:200(room tempeRature, 30min). Negative control was used by secondary antibody only. |
|
| |
